Why the study?
Although the diagnosis and treatment of UEDVT share similarities with lower extremity DVT, knowledge of specific aspects regarding UEDVT is important to guide optimal management.
This review summarizes the epidemiology, diagnosis, and treatment of upper extremity deep vein thrombosis, highlighting the importance of early recognition and prompt anticoagulant treatment.
Supports early UEDVT recognition and anticoagulation; extends evidence synthesis while leaving optimal protocols open.
Upper extremity deep vein thrombosis (UEDVT) accounts for 5% of all deep vein thromboses (DVTs). UEDVT may be complicated by post thrombotic syndrome and pulmonary embolism, and early recognition and prompt start of anticoagulant treatment are key. Primary UEDVT, also known as Paget-von Schrötter syndrome, is associated with repeated or sudden physical activity of the upper arm and venous outflow obstruction due to anatomical variations. Secondary UEDVT is often associated with malignancy or use of intravenous devices, such as central venous catheters or pacemaker leads. Although the diagnosis and treatment of UEDVT have many similarities with DVT of the lower extremities, knowledge of specific aspects regarding UEDVT is important to guide optimal management. In this review, we will discuss the epidemiology, diagnosis, and treatment of UEDVT based on the current literature.
No takes yet. Share an insight, caveat, or question.
Bosch et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: